SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) shares were down 1.2% during mid-day trading on Wednesday . The company traded as low as $24.38 and last traded at $24.38. Approximately 200 shares changed hands during trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Trading Down 1.2 %
The business’s fifty day moving average price is $24.38 and its 200 day moving average price is $24.38. The firm has a market capitalization of $6.64 billion, a price-to-earnings ratio of 48.76, a PEG ratio of 1.30 and a beta of 1.81.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
See Also
- Five stocks we like better than SWEDISH ORPHAN/S
- What is a Dividend King?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What is a buyback in stocks? A comprehensive guide for investors
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What is a Bond Market Holiday? How to Invest and Trade
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
